| top | topical |
|---|---|
| OBB | own bed bath |
| PB | British pharmacopeia [Pharmacopoeia Britannica]; paraffin bath; Paul-Bunnell [antibody]; periodic br... |
| TB | Taussig-Bind [syndrome]; terabyte; term birth; terminal bronchiole; terminal bronchus; thromboxane B... |
| WPB | whirlpool bath |
| sitz bath | Immersion of only the perineum and buttocks, with the legs being outside the tub. Origin: Ger. Sitzen, to sit (05 Mar 2000) |
|---|---|
| Nauheim bath | Treatment of certain cardiac affections by baths in water through which carbonic acid gas is bubbling, followed by resisting exercises. Synonym: Nauheim bath, Schott treatment. Origin: Bad Nauheim, W. Germany (05 Mar 2000) |
| needle bath | A bath in which water is projected forcibly against the body in many very fine jets. (05 Mar 2000) |
| douche bath | The local application of water in the form of a large jet or stream. (05 Mar 2000) |
| dousing bath | A luminous electric hot air bath given at a very high temperature. (05 Mar 2000) |
| immersion bath | A therapeutic bath in which the whole person or a body part is totally immersed in the therapeutic substance. (05 Mar 2000) |
| oil bath | In chemistry, a vessel containing oil, in which a container holding a substance to be heated or evaporated can be immersed. (05 Mar 2000) |
| electric bath | A bath in which the medium is charged with electricity. Synonym: hydroelectric bath. Therapeutic application of static electricity, with the patient placed on an insulated platform. (05 Mar 2000) |
| light bath | Therapeutic exposure of the skin to radiant light. (05 Mar 2000) |
| biological products | Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms. (12 Dec 1998) |
| blood products | Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered. (14 Nov 1997) |
| gene products, env | Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesised as protein precursors (polyproteins) and later cleaved into the final products by a viral protease. (12 Dec 1998) |
| gene products, gag | Proteins coded by the retroviral gag gene. The products are usually synthesised as protein precursors or polyproteins, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. Gag is short for group-specific antigen. (12 Dec 1998) |
| gene products, nef | Products of the HIV nef gene (formerly 3'-orf gene). The products trans-suppress viral replication and function as negative regulators of transcription. Nef stands for negative factor. (12 Dec 1998) |
| gene products, pol | Retroviral proteins coded by the pol gene. Often synthesised as a gag-pol fusion protein (fusion proteins, gag-pol) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Pol is short for polymerase, the enzyme class of reverse transcriptase. (12 Dec 1998) |